| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| MAHON PAUL A | EVP & GENERAL COUNSEL | C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING | /s/ John S. Hess, Jr. under Power of Attorney | 02 Oct 2025 | 0001231589 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Common Stock | Options Exercise | $1,489,620 | +11,000 | +29.9% | $135.42 | 47,781 | 02 Oct 2025 | Direct | |
| transaction | UTHR | Common Stock | Sale | $-620,224 | -1,430 | -2.99% | $433.72 | 46,351 | 02 Oct 2025 | Direct | F1, F2 |
| transaction | UTHR | Common Stock | Sale | $-795,574 | -1,828 | -3.94% | $435.22 | 44,523 | 02 Oct 2025 | Direct | F1, F3 |
| transaction | UTHR | Common Stock | Sale | $-820,566 | -1,881 | -4.22% | $436.24 | 42,642 | 02 Oct 2025 | Direct | F1, F4 |
| transaction | UTHR | Common Stock | Sale | $-1,370,905 | -3,136 | -7.35% | $437.15 | 39,506 | 02 Oct 2025 | Direct | F1, F5 |
| transaction | UTHR | Common Stock | Sale | $-834,710 | -1,905 | -4.82% | $438.17 | 37,601 | 02 Oct 2025 | Direct | F1, F6 |
| transaction | UTHR | Common Stock | Sale | $-151,959 | -346 | -0.92% | $439.19 | 37,255 | 02 Oct 2025 | Direct | F1, F7 |
| transaction | UTHR | Common Stock | Sale | $-208,636 | -474 | -1.27% | $440.16 | 36,781 | 02 Oct 2025 | Direct | F1, F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | UTHR | Stock Option | Options Exercise | $0 | -11,000 | -20% | $0.000000 | 44,000 | 02 Oct 2025 | Common Stock | 11,000 | $135.42 | Direct | F1 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024. |
| F2 | This transaction was executed in multiple trades at prices ranging from $433.135 to $433.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | This transaction was executed in multiple trades at prices ranging from $434.66 to $435.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $435.70 to $436.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $436.70 to $437.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $437.72 to $438.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $438.90 to $439.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $439.945 to $440.62. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |